Thibault Boutherin
Stock Analyst at Morgan Stanley
(0.62)
# 3,832
Out of 5,055 analysts
4
Total ratings
50%
Success rate
-11.02%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALVO Alvotech | Upgrades: Overweight | $14 | $5.49 | +155.01% | 2 | Oct 14, 2025 | |
| NVO Novo Nordisk | Downgrades: Underweight | $59 → $47 | $48.26 | -2.61% | 1 | Sep 29, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Equal-Weight | $10 | $25.41 | -60.65% | 1 | May 25, 2023 |
Alvotech
Oct 14, 2025
Upgrades: Overweight
Price Target: $14
Current: $5.49
Upside: +155.01%
Novo Nordisk
Sep 29, 2025
Downgrades: Underweight
Price Target: $59 → $47
Current: $48.26
Upside: -2.61%
Teva Pharmaceutical Industries
May 25, 2023
Initiates: Equal-Weight
Price Target: $10
Current: $25.41
Upside: -60.65%